Clinical Trials Browser

Interventional × Standard of Care × Dermatologic × Clear all

NCT06391099 2026-05-26

Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer

Phase NA Suspended

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma

NCT06585410 2026-04-22

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

Phase 3 Recruiting

Skin Neoplasms

NCT06539468 2026-04-14

Active Surveillance for the Treatment of Low-Risk Basal Cell Carcinoma in Elderly Patients

Phase NA Recruiting

Carcinoma, Basal Cell

NCT07241585 2026-03-17

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Phase NA Not yet recruiting

Carcinoma, Basal Cell, Carcinoma, Squamous Cell

NCT02645149 2026-02-27

Match Mel

Phase 2 Completed

Melanoma

NCT07379138 2026-01-30

Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients

Phase NA Recruiting

Melanoma

NCT03154190 2025-01-24

Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer

Phase NA Completed

128 enrolled 24 charts

BreastDermatologicGastrointestinalGenitourinaryGynecologicMyeloidOther hematologic neoplasmSarcomaThoracic

Urinary Bladder Neoplasms, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Melanoma, Myelodysplastic Syndromes, Ovarian Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Leukemia, Myeloid, Acute, Disease Progression, Triple Negative Breast Neoplasms

NCT05110924 2024-12-17

BASINEL

Phase NA Terminated

Carcinoma, Basal Cell

NCT06470880 2024-06-24

DyNAMIc

Phase 2 Not yet recruiting

Melanoma

NCT03725449 2022-11-14

Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma

Phase NA Completed

Dysplastic Nevus Syndrome, Melanoma

NCT02451488 2020-02-10

Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma

Phase 4 Completed

8 enrolled 5 charts

Melanoma

NCT01010334 2013-08-14

Comparison of Standard of Care or Treatment on Protocol

Phase NA Terminated

DermatologicGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Skin Neoplasms, Stomach Neoplasms, Uterine Neoplasms